SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040112
Filing Date
2023-11-09
Accepted
2023-11-09 17:15:11
Documents
13
Period of Report
2023-11-09
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41953
2 ex16-1.htm EX-16.1 4415
  Complete submission text file 0001493152-23-040112.txt   225408

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dare-20231109.xsd EX-101.SCH 3033
4 XBRL LABEL FILE dare-20231109_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE dare-20231109_pre.xml EX-101.PRE 22801
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3457
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 231393746
SIC: 2834 Pharmaceutical Preparations